Iceland’s strategy to track the spread of the coronavirus can be used in the U.S., deCODE Genetics CEO Kari Stefansson said on Wednesday. How Iceland contains the spread of disease is by testing and robust contact tracing.
Stefansson, whose Reykjavík-based biopharmaceutical company is known for its work analyzing the human genome, noted the obvious size differences between the U.S. and Iceland.
For starters, the U.S. has about 330 million people while Iceland has just about 347,000, according to the U.S. Census Bureau.
But Iceland’s ability to test around 10% of its population and deploy robust contact tracing when someone is diagnosed with Covid-19 should not be seen as something only small countries can do, Stefansson said in an interview with CNBC’s Meg Tirrel.